These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21732158)

  • 1. Macrophage-specific targeting of isoniazid through mannosylated gelatin microspheres.
    Tiwari S; Chaturvedi AP; Tripathi YB; Mishra B
    AAPS PharmSciTech; 2011 Sep; 12(3):900-8. PubMed ID: 21732158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis.
    Saraogi GK; Sharma B; Joshi B; Gupta P; Gupta UD; Jain NK; Agrawal GP
    J Drug Target; 2011 Apr; 19(3):219-27. PubMed ID: 20540651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
    Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
    Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
    Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
    J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.
    Parikh R; Dalwadi S; Aboti P; Patel L
    J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microencapsulation of isoniazid in genipin-crosslinked gelatin-A-κ-carrageenan polyelectrolyte complex.
    Devi N; Maji TK
    Drug Dev Ind Pharm; 2010 Jan; 36(1):56-63. PubMed ID: 19681667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of biodegradable flubiprofen gelatin micro-spheres for intra-articular administration.
    Lu Y; Zhang G; Sun D; Zhong Y
    J Microencapsul; 2007 Sep; 24(6):515-24. PubMed ID: 17654172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis.
    Chaubey P; Patel RR; Mishra B
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung-targeted delivery system of curcumin loaded gelatin microspheres.
    Cao F; Ding B; Sun M; Guo C; Zhang L; Zhai G
    Drug Deliv; 2011 Nov; 18(8):545-54. PubMed ID: 21812751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboxymethyl chitosan microspheres loaded hyaluronic acid/gelatin hydrogels for controlled drug delivery and the treatment of inflammatory bowel disease.
    Zhang S; Kang L; Hu S; Hu J; Fu Y; Hu Y; Yang X
    Int J Biol Macromol; 2021 Jan; 167():1598-1612. PubMed ID: 33220374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
    Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
    Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microparticle-based lung delivery of INH decreases INH metabolism and targets alveolar macrophages.
    Zhou H; Zhang Y; Biggs DL; Manning MC; Randolph TW; Christians U; Hybertson BM; Ng KY
    J Control Release; 2005 Oct; 107(2):288-99. PubMed ID: 16009444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages.
    Chono S; Kaneko K; Yamamoto E; Togami K; Morimoto K
    Drug Dev Ind Pharm; 2010 Jan; 36(1):102-7. PubMed ID: 19656002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery.
    Kawadkar J; Jain R; Kishore R; Pathak A; Chauhan MK
    J Drug Target; 2013 Feb; 21(2):200-10. PubMed ID: 23249324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring of alginate-gelatin microspheres properties for oral Ciprofloxacin-controlled release against Pseudomonas aeruginosa.
    Islan GA; Castro GR
    Drug Deliv; 2014 Dec; 21(8):615-26. PubMed ID: 24401147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual antitubercular drug loaded liposomes for macrophage targeting: development, characterisation,
    Shrivastava P; Gautam L; Sharma R; Dube D; Vyas S; Vyas SP
    J Microencapsul; 2021 Mar; 38(2):108-123. PubMed ID: 33267623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of a biodegradable drug targeting system for anticancer drug delivery: microsphere-antibody conjugate.
    Muvaffak A; Gurhan I; Gunduz U; Hasirci N
    J Drug Target; 2005 Apr; 13(3):151-9. PubMed ID: 16036303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats.
    Wijagkanalan W; Kawakami S; Takenaga M; Igarashi R; Yamashita F; Hashida M
    J Control Release; 2008 Jan; 125(2):121-30. PubMed ID: 18037185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.